The Impact of Beef on Muscle Fatigue in Older Adults

Sponsor
Indiana University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05860088
Collaborator
(none)
30
1
2
17.1
1.8

Study Details

Study Description

Brief Summary

The goal of this controlled-feeding cross-over diet intervention is to compare a beef diet to a vegetarian diet on muscle fatigue in older adults. The aims are:

AIM 1: To test the hypothesis that muscle fatigue is attenuated in older adults consuming beef compared to older adults consuming a plant-based diet.

AIM2: To test the hypothesis that daily beef consumption improves biochemical indicators related to muscle fatigue.

Participants will be randomized to consume either a beef-based diet or vegetarian diet under controlled-feeding conditions for 8 weeks. After a 2-week washout period, participants will cross-over to consume either the beef diet or vegetarian diet for 8 weeks. Body composition and functional muscle outcomes will be measured during each 8-week feeding period. Blood samples will also be collected.

Condition or Disease Intervention/Treatment Phase
  • Other: Beef Diet
  • Other: Vegetarian Diet
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Beta-Alanine and Carnosine From Beef Intake on Muscle Fatigue in Older Adults
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Beef Diet

Participants will be randomized to consume the beef diet for 8 weeks. After a 2-week period, participants will cross-over to consume the vegetarian diet for 8 weeks.

Other: Beef Diet
Controlled-Feeding Diet Intervention

Experimental: Vegetarian Diet

Participants will be randomized to consume the vegetarian diet for 8 weeks. After a 2-week period, participants will cross-over to consume the beef diet for 8 weeks.

Other: Vegetarian Diet
Controlled-Feeding Diet Intervention

Outcome Measures

Primary Outcome Measures

  1. The change in muscle strength [Weeks 0, 4, 8]

    Sit-to-stand

  2. The change in muscle function [Weeks 0,4,6]

    6-minute walk

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion Criteria

  • Ages 60-75 years

  • Ability to eat study diet meals for a total of 16 weeks

  • Ability to perform sit-to-stand chair and 6-minute walking tests based on results from PAR-Q questionnaire

  • Ability to provide fasted blood samples

  • Access to transportation

  • Willing to abstain from alcohol consumption and/or use illicit drug use for each 8-week intervention period

  • Ability to consent to participating in this study

  • English-speaking

  • Body mass index between 18.5 (normal) and 39.9 (obese) kg/m2

  • Minimum total body weight of 110 pounds

  • Non-anemia hemoglobin values: Females - >12.0 grams/dL; Men - >13.0 grams/dL

  • Able to ambulate without assistance

  • Physician's clearance for study participation (required prior to baseline testing)

Exclusion Criteria

  • Inability or refusal to sign the informed consent

  • Significant orthopedic limitations or other contraindications to exercise

  • Inability or refusal to perform muscle fatigue tests

  • Has dietary restrictions that prevent to consumption of beef, soy and/or wheat

  • Has liver or kidney complications

  • Live or work >50 miles from Bloomington study site or does not have transportation to the study site

  • Anticipate elective surgery during the study period

  • Diagnosis of progressive neurological disorders, musculoskeletal disorders, osteoarthritis, rheumatoid arthritis

  • Fracture or serious injury in the last 6 months

  • Stroke, revascularization, deep vein thrombosis, or pulmonary embolism in the past 12 months

  • Severe cardiovascular disease, uncontrolled systemic hypertension, chronic pulmonary disease

  • Plan to move residence or travel out of the local area during the study period

  • Current use of anti-coagulants (e.g. Coumadin or Warfarin)

  • Current use of prescription medications that affect heart rate or blood vessel dilation

  • Psychological or social characteristics that would interfere with their ability to fully participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Indiana University Bloomington Bloomington Indiana United States 47405

Sponsors and Collaborators

  • Indiana University

Investigators

  • Principal Investigator: Cydne A Perry, PhD, Indiana University Bloomington

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cydne Perry, PhD, Assistant Professor, Indiana University
ClinicalTrials.gov Identifier:
NCT05860088
Other Study ID Numbers:
  • 14941
First Posted:
May 16, 2023
Last Update Posted:
May 16, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cydne Perry, PhD, Assistant Professor, Indiana University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2023